Abbott Laboratories Redburn Upgrade Analysis: Volt PFA, Libre and Cologuard at 16x Forward Earnings — Why We See $115 Base-Case Value
Abbott Redburn upgrade analysis: Volt PFA, Libre and Cologuard growth at 16x forward earnings, with a $115 base-case target and bull/bear scenarios.
